Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly.

Suleyman Nahit Sendur Tuncay HazirolanBusra Aydinİncilay LayMehmet AlikasifogluTomris Erbas

Published in: Acta cardiologica (2021)

Serum FSTL1 levels are not associated with functional and structural measures of myocardium in patients with acromegaly. However, the risk of left ventricular hypertrophy is reduced in CC genotyped individuals of FSTL1.

Keyphrases

left ventricular
heart failure
growth hormone
acute myocardial infarction
cardiac resynchronization therapy
aortic stenosis
acute coronary syndrome
atrial fibrillation
transcatheter aortic valve replacement
ejection fraction